Serotonin 2A receptors differentially contribute to abuse-related effects of cocaine and cocaine-induced nigrostriatal and mesolimbic dopamine overflow in nonhuman primates

Journal of Neuroscience

Volumn 33, Issue 33, 2013, Pages 13367-13374

  Murnane, Kevin S ^a   Winschel, Jake ^a   Schmidt, Karl T ^a   Stewart, Lashaya M ^a   Rose, Samuel J ^a   Cheng, Kejun ^c   Rice, Kenner C ^c   Howell, Leonard L ^a,b  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; SEROTONIN 2A ANTAGONIST; SEROTONIN 2A RECEPTOR; VOLINANSERIN;

ABSTINENCE; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CAUDATE NUCLEUS; CONTROLLED STUDY; DOPAMINE BLOOD LEVEL; DOPAMINERGIC TRANSMISSION; DRUG ABUSE; DRUG SELF ADMINISTRATION; FEMALE; MALE; MESOLIMBIC DOPAMINERGIC SYSTEM; MICRODIALYSIS; NERVE CELL NETWORK; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; REINFORCEMENT; RHESUS MONKEY; SUBSTANTIA NIGRA;

ANIMALS; BRAIN; COCAINE-RELATED DISORDERS; DOPAMINE; FEMALE; FLUOROBENZENES; MACACA MULATTA; MICRODIALYSIS; PIPERIDINES; RECEPTOR, SEROTONIN, 5-HT2A; SEROTONIN ANTAGONISTS;

EID: 84881488888     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.1437-13.2013     Document Type: Article

References (52)

1. Andersen ML, Kessler E, Murnane KS, McClung JC, Tufik S, Howell LL (2010) Dopamine transporter-related effects of modafinil in rhesus monkeys. Psychopharmacology (Berl) 210:439-448.
2. Auclair A, Blanc G, Glowinski J, Tassin JP (2004) Role of serotonin 2A receptorsin the D-amphetamine-induced releaseofdopamine: comparison with previous data on alpha1b-adrenergic receptors. J Neurochem 91: 318-326.
3. Banks ML, Andersen ML, Murnane KS, Meyer RC, Howell LL (2009) Behavioral and neurochemical effects of cocaine and diphenhyd-ramine combinations in rhesus monkeys. Psychopharmacology (Berl) 205:467-474.
4. Belin D, Everitt BJ (2008) Cocaine seeking habits depend upon dopamine-dependent serial connectivity linking the ventral with the dorsal striatum. Neuron 57:432-441.
5. Bortolozzi A, Díaz-Mataix L, Scorza MC, Celada P, Artigas F (2005) The activation of 5-HT receptors in prefrontal cortex enhances dopaminergic activity. J Neurochem 95:1597-1607.
6. Davidson C, Lazarus C, Lee TH, Ellinwood EH (2004) Ondansetron, given during the acute cocaine withdrawal, attenuates oral cocaine self-administration. Eur J Pharmacol 503:99-102.
7. Doherty MD, Pickel VM (2000) Ultrastructural localization of the serotonin 2A receptor in dopaminergic neurons in the ventral tegmental area. Brain Res 864:176-185.
8. Egerton A, Ahmad R, Hirani E, Grasby PM (2008) Modulation of striatal dopamine release by5-HT2A and 5-HT2C receptor antagonists: [11C]ra-clopride PET studiesin the rat. Psychopharmacology (Berl) 200:487-496.
9. Fantegrossi WE, Ullrich T, Rice KC, Woods JH, Winger G (2002) 3,4-Methylenedioxymethamphetamine (MDMA, "ecstasy") and its stereo-isomers as reinforcers in rhesus monkeys: serotonergic involvement. Psychopharmacology (Berl) 161:356-364.
10. Fantegrossi WE, Woods JH, Winger G (2004) Transient reinforcing effects of phenylisopropylamine and indolealkylamine hallucinogens in rhesus monkeys. Behav Pharmacol 15:149-157.
11. Fantegrossi WE, Bauzo RM, Manvich DM, Morales JC, Votaw JR, Goodman MM, Howell LL (2009) Role of dopamine transporters in the behavioral effectsof3,4-methylenedioxymethamphetamine (MDMA)innonhuman primates. Psychopharmacology (Berl) 205:337-347.
12. Fletcher PJ, Grottick AJ, Higgins GA (2002) Differential effects of the 5-HT(2A) receptor antagonist M100907 and the 5-HT(2C) receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding. Neuropsychopharmacology 27:576-586.
13. Gewirtz JC, Marek GJ (2000) Behavioral evidence for interactions between a hallucinogenic drug and group II metabotropic glutamate receptors. Neuropsychopharmacology 23:569-576.
14. Haber SN, Knutson B (2010) The reward circuit: linking primate anatomy and human imaging. Neuropsychopharmacology 35:4-26.
15. Haber SN, Fudge JL, McFarland NR (2000) Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral stria-tum. J Neurosci 20:2369-2382.
16. Haber SN, Kim KS, Mailly P, Calzavara R (2006) Reward-related cortical inputs define a large striatal region in primates that interface with associative cortical connections, providing a substrate for incentive-based learning. J Neurosci 26:8368-8376.
17. Henry PK, Murnane KS, Votaw JR, Howell LL (2010) Acute brain metabolic effects of cocaine in rhesus monkeys with a history of cocaine use. Brain Imaging Behav 4:212-219.
18. Howell LL, Murnane KS (2008) Nonhuman primate neuroimaging and the neurobiology of psychostimulant addiction. Ann N Y Acad Sci 1141:176-194.
19. Howell LL, Hoffman JM, Votaw JR, Landrum AM, Wilcox KM, Lindsey KP (2002) Cocaine-induced brain activation determined by positron emission tomography neuroimaging in conscious rhesus monkeys. Psycho-pharmacology (Berl) 159:154-160.
20. Howell LL, Votaw JR, Goodman MM, Lindsey KP (2010) Cortical activation during cocaine use and extinction in rhesus monkeys. Psychopharmacology (Berl) 208:191-199.
21. Ikemoto K, Nishimura A, Okado N, Mikuni M, Nishi K, Nagatsu I (2000) Human midbrain dopamine neurons express serotonin 2A receptor: an immunohistochemical demonstration. Brain Res 853:377-380.
22. Ito R, Dalley JW, Robbins TW, Everitt BJ (2002) Dopamine release in the dorsal striatum during cocaine-seeking behavior under the control of a drug-associated cue. J Neurosci 22:6247-6253.
23. Jakab RL, Goldman-Rakic PS (1998) 5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites. Proc Natl Acad Sci U S A 95:735-740.
24. Johnston LD, O'Malley PM, Bachman JG, Schulenberg JE (2011) Monitoring the Future national survey results on drug use, 1975-2010, Vol I: secondary school students. Ann Arbor, MI: Institute for Social Research, The University of Michigan.
25. Kalivas PW (2007) Cocaine and amphetamine-like psychostimulants: neurocircuitry and glutamate neuroplasticity. Dialogues Clin Neurosci 9:389-397.
26. Kalivas PW (2009) The glutamate homeostasis hypothesis of addiction. Nat Rev Neurosci 10:561-572.
27. Katz JL, Higgins ST (2003) The validity of the reinstatement model of craving and relapse to drug use. Psychopharmacology (Berl) 168:21-30.
28. Kimmel HL, Manvich DF, Blough BE, Negus SS, Howell LL (2009) Behavioral and neurochemical effects of amphetamine analogs that release monoamines in the squirrel monkey. Pharmacol Biochem Behav 94:278-284.
29. Kirkland Henry P, Davis M, Howell LL (2009) Effects of cocaine self-administration history under limited and extended access conditions on in vivo striatal dopamine neurochemistry and acoustic startle in rhesus monkeys. Psychopharmacology (Berl) 205:237-247.
30. Lessard A, Savard M, Gobeil F Jr, Pierce JP, Pickel VM (2009) The neurokinin-3 (NK3) and the neurokinin-1 (NK1) receptors are differentially targeted to mesocortical and mesolimbic projection neurons and to neuronal nuclei in the rat ventral tegmental area. Synapse 63:484-501.
31. McFarland K, Lapish CC, Kalivas PW (2003) Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behavior. J Neurosci 23:3531-3537.
32. McMahon LR, Filip M, Cunningham KA (2001) Differential regulation of the mesoaccumbens circuit byserotonin 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors. J Neurosci 21:7781-7787.
33. Mello NK, Negus SS (1996) Preclinical evaluationof pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures. Neuropsychopharmacology 14:375-424.
34. Murnane KS, Howell LL (2010) Development of an apparatus and methodology for conducting functional magnetic resonance imaging (fMRI) with pharmacological stimuli in conscious rhesus monkeys. J Neurosci Methods 191:11-20.
35. Murnane KS, Fantegrossi WE, Godfrey JR, Banks ML, Howell LL (2010) Endocrine and neurochemical effects of 3,4-methylenedioxymethamphetamine and its stereoisomers in rhesus monkeys. J Pharmacol Exp Ther 334: 642-650.
36. Murnane KS, Kimmel HL, Rice KC, Howell LL (2012) The neuropharmacol-ogy of prolactin secretion elicited by 3,4-methylenedioxymethamphetamine ("ecstasy"): a concurrent microdialysis and plasma analysis study. Horm Behav 61:181-190.
37. Murnane KS, Andersen ML, Rice KC, Howell LL (2013) Selective serotonin 2A receptor antagonism attenuates the effects ofamphetamine on arousal and dopamine overflow in non-human primates. J Sleep Res, in press.
38. Nic Dhonnchadha BA, Fox RG, Stutz SJ, Rice KC, Cunningham KA (2009) Blockade of the serotonin 5-HT2A receptor suppresses cue-evoked reinstatement of cocaine-seeking behavior in a rat self-administration model. Behav Neurosci 123:382-396.
39. Nocjar C, Roth BL, Pehek EA (2002) Localizationof 5-HT(2A) receptors on dopamine cellsinsubnucleiof the midbrain A10 cell group. Neuroscience 111:163-176.
40. O'Brien CP, Gardner EL (2005) Critical assessment of how to study addiction and its treatment: human and nonhuman animal models. Pharmacol Ther 108:18-58.
41. Pehek EA, McFarlane HG, Maguschak K, Price B, Pluto CP (2001) M100,907, a selective 5-HT(2A) antagonist, attenuates dopamine release in the rat medial prefrontal cortex. Brain Res 888:51-59.
42. Pehek EA, Nocjar C, Roth BL, Byrd TA, Mabrouk OS (2006) Evidence for the preferential involvementof 5-HT2A serotonin receptors instress- and drug-induced dopamine release in the rat medial prefrontal cortex. Neu-ropsychopharmacology 31:265-277.
43. Porrino LJ, Smith HR, Nader MA, Beveridge TJ (2007) The effects of cocaine: a shifting target over the course of addiction. Prog Neuropsychopharmacol Biol Psychiatry 31:1593-1600.
44. Rodríguez JJ, Doherty MD, Pickel VM (2000) N-methyl-D-aspartate (NMDA) receptors in the ventral tegmental area: subcellular distribution and colocalization with 5-hydroxytryptamine(2A) receptors. J Neurosci Res 60:202-211.
45. Sawyer EK, Mun J, Nye JA, Kimmel HL, Voll RJ, Stehouwer JS, Rice KC, Goodman MM, Howell LL (2012) Neurobiological changes mediating the effects of chronic fluoxetine on cocaine use. Neuropsychopharmacol-ogy 37:1816-1824.
46. Scruggs JL, Schmidt D, Deutch AY (2003) The hallucinogen 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI) increases cortical extracellular glutamate levels in rats. Neurosci Lett 346:137-140.
47. Siegel RK, Jarvik ME (1980) DMT self-administration by monkey in isolation. Bull Psychon Soc 16:117-120.
48. Stewart J, de Wit H (1987) Reinstatement of drug-taking behavior as a method of assessing incentive motivational properties of drugs. In: Methods of assessing the reinforcing properties of abused drugs (Bozarth MA, ed), pp 211-227. New York: Springer.
49. Wilcox KM, Lindsey KP, Votaw JR, Goodman MM, Martarello L, Carroll FI, Howell LL (2002) Self-administration of cocaine and the cocaine analog RTI-113: relationship to dopamine transporter occupancy determined by PET neuroimaging in rhesus monkeys. Synapse 43:78-85.
50. Wilcox KM, Kimmel HL, Lindsey KP, Votaw JR, Goodman MM, Howell LL (2005) In vivo comparison of the reinforcing and dopamine transporter effects of local anesthetics in rhesus monkeys. Synapse 58:220-228.
51. Zayara AE, McIver G, Valdivia PN, Lominac KD, McCreary AC, Szumlin-ski KK (2011) Blockade of nucleus accumbens 5-HT2A and 5-HT2C receptors prevents the expression of cocaine-induced behavioral and neurochemical sensitization in rats. Psychopharmacology (Berl) 213: 321-335.
52. Zhang C, Marek GJ (2008) AMPA receptor involvement in 5-hydroxytryptamine2A receptor-mediated prefrontal cortical excitatory synaptic currents and DOI-induced head shakes. Prog Neuropsychopharmacol Biol Psychiatry 32:62-71.